Stock Research: Johnson & Johnson

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Johnson & Johnson

NYQ:JNJ US4781601046
62
  • Value
    66
  • Growth
    47
  • Safety
    Safety
    47
  • Combined
    45
  • Sentiment
    99
  • 360° View
    360° View
    62
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Johnson & Johnson researches, develops, manufactures, and sells healthcare products. It operates in the healthcare field through two segments: Innovative Medicine and MedTech. Medicines are distributed worldwide. In the last fiscal year, the company had a market cap of $373,350 million, profits of $61,385 million, revenue of $88,821 million, and 138,100 employees.

more
Index
Dow Jones
D.J. US Health Care
D.J. US Pharmaceutical
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
66 51 60 65
Growth
47 41 25 51
Safety
Safety
47 56 73 72
Sentiment
99 54 10 75
360° View
360° View
62 43 27 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
14 26 17 38
Opinions Change
90 50 6 66
Pro Holdings
n/a 94 76 36
Market Pulse
96 37 26 86
Sentiment
99 54 10 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
66 51 60 65
Growth
47 41 25 51
Safety Safety
47 56 73 72
Combined
45 45 56 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
45 24 20 20
Price vs. Earnings (P/E)
47 48 54 58
Price vs. Book (P/B)
17 12 18 20
Dividend Yield
98 94 96 96
Value
66 51 60 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
32 33 34 27
Profit Growth
60 35 46 66
Capital Growth
31 58 23 42
Stock Returns
67 51 49 75
Growth
47 41 25 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
30 51 55 67
Refinancing
10 12 21 13
Liquidity
93 96 98 96
Safety Safety
47 56 73 72

Similar Stocks

Discover high‑ranked alternatives to Johnson & Johnson and broaden your portfolio horizons.

Sandisk

NSQ:SNDK
Country: USA
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: